Morgan Stanley Agios Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 348,973 shares of AGIO stock, worth $20.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

348,973

Previous 596,675 41.51%

Holding current value

$20.5 Million

Previous $25.7 Million 39.74%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $10.2 Million - $12.3 Million	-247,702 Reduced 41.51%	348,973 $15.5 Million
Q2 2024 Oct 17, 2024	SELL	$27.55 - $48.83 $16.1 Million - $28.5 Million	-583,651 Reduced 49.45%	596,675 $25.7 Million
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $16.1 Million - $28.5 Million	-583,651 Reduced 49.45%	596,675 $25.7 Million
Q1 2024 Oct 17, 2024	BUY	$21.32 - $34.81 $12.4 Million - $20.3 Million	583,651 Added 97.82%	1,180,326 $34.5 Million
Q1 2024 Aug 16, 2024	BUY	$21.32 - $34.81 $14.6 Million - $23.9 Million	686,739 Added 139.13%	1,180,326 $34.5 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $14.6 Million - $23.9 Million	686,739 Added 139.13%	1,180,326 $34.5 Million
Q4 2023 Aug 16, 2024	SELL	$19.97 - $24.53 $2.06 Million - $2.53 Million	-103,088 Reduced 17.28%	493,587 $11 Million
Q4 2023 Feb 13, 2024	BUY	$19.97 - $24.53 $2.39 Million - $2.93 Million	119,458 Added 31.93%	493,587 $11 Million
Q3 2023 Nov 15, 2023	SELL	$24.36 - $28.18 $422,353 - $488,584	-17,338 Reduced 4.43%	374,129 $9.26 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $1.73 Million - $2.36 Million	80,685 Added 25.96%	391,467 $11.1 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $1.21 Million - $1.72 Million	-55,737 Reduced 15.21%	310,782 $7.14 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $2.16 Million - $2.74 Million	86,988 Added 31.12%	366,519 $10.3 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $2.67 Million - $4.66 Million	-136,605 Reduced 32.83%	279,531 $7.91 Million
Q2 2022 Oct 27, 2022	BUY	$17.06 - $31.42 $1.46 Million - $2.69 Million	85,605 Added 25.9%	416,136 $9.23 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $1.46 Million - $2.69 Million	85,605 Added 25.9%	416,136 $9.23 Million
Q1 2022 Oct 27, 2022	SELL	$26.68 - $34.81 $2.28 Million - $2.98 Million	-85,605 Reduced 20.57%	330,531 $9.62 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $1.94 Million - $2.53 Million	72,595 Added 28.14%	330,531 $9.62 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $2.41 Million - $4.06 Million	81,643 Added 46.31%	257,936 $8.48 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $7.39 Million - $10.3 Million	176,293 New	176,293 $8.14 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.23B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account